Form 4: Maravai LifeSciences Executive Christine Dolan Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Christine Dolan, an executive at Maravai LifeSciences, reported the disposal of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 17, 2025, Christine Dolan, Executive Vice President and General Manager, Cygnus Technologies at Maravai LifeSciences Holdings, Inc., disposed of 5,336 shares of Class A Common Stock.
- The disposal was to satisfy tax withholding obligations related to the vesting of restricted stock unit awards.
- The price per share was $2.64.
- Following the transaction, Dolan beneficially owns 224,677 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. This transaction is related to tax obligations, which is a common occurrence when restricted stock units vest.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of stock disposal transaction |
| 03/19/2025 | Date of signature on the Form 4 filing |
Keywords
Form 4, Maravai LifeSciences, MRVI, Christine Dolan, Stock Disposal, Tax Withholding, Restricted Stock Units, Beneficial Ownership, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.